Charleston, SC -- (SBWIRE) -- 08/23/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: MRI Interventions Inc (OTCBB:MRIC), Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY), Soligenix Inc (OTCBB:SNGX), Growlife Inc (OTCBB:PHOT)
MRI Interventions Inc (OTCBB:MRIC) increased +2.16% and closed at $1.42 on a traded volume of 569,479 shares, in comparison to 111,997 shares of average trading volume. So far this year, the stock is down over -11.25%.
The company has a total market capitalization of $82.81 million and its total outstanding shares are 58.32 million. MRI Interventions, Inc., a medical device company, develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance primarily in the United States.
Why Should Investors Buy MRIC After The Recent Gain? Just Go Here and Find Out
Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) plunged -1.88% and closed at $8.87 on a traded volume of 98,712 shares, whereas its average trading volume is 84,256 shares. In the last three months, the stock is down -7.12%. The Intra-day range for the stock is $8.65 and $9.00.
Telecom Corporation of New Zealand Limited, together with its subsidiaries, provides telecommunications services, information technology (IT) services, and network services in New Zealand and Australia.
Will NZTCY Get Buyers Even After The Recent Rally? Find Out Here
Soligenix Inc (OTCBB:SNGX) dropped down -1.25% and closed at $1.58. So far in three months, the stock is up -33.90%. The 52-week range for the stock is $0.30 and $2.13 and during the previous trading session the stock touched its highest price at $1.75. Its introductory price for the day was $1.70, with the overall traded volume of 177,322 shares.
Soligenix, Inc., a development stage biopharmaceutical company, engages in developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents.
Has SNGX Found The Bottom And Ready To Gain Momentum? Find Out Here
Growlife Inc (OTCBB:PHOT), after opening its shares at the price of $0.03, dropped -3.23% to close at $0.0300 for the day. The stock moved on a traded volume of 4.17 million shares, in comparison to 4.46 million shares of average trading volume.
The 52-week range for the stock is $0.0042 and $0.12 and during the previous trading session the stock touched its highest price at $0.0324. Its introductory price for the day was $0.0307. Growlife, Inc., through its subsidiaries, manufactures and markets horticulture and lifestyle products in the United States and internationally. It offers LED lights for indoor growing; wireless monitoring and control equipment to operate grow room functions; and plant growing systems and accessories, including nutrients, media, timers, controls, and automated water accessories.
Why Should Investors Buy PHOT After the Recent Fall? Just Go Here and Find Out
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)